The report "Fill Finish Manufacturing Market by Product (Consumables (Pre-fillable Syringes (Plunger Stopper)), Vial (Glass, Plastic), Cartridge), Instruments ((Standalone, Integrated Systems), Automated Machines), End User (CMO, Pharma) - Global Forecast to 2029", is projected to reach USD 25.7 billion by 2029 from USD 16.7 billion in 2024, at a CAGR of 8.9% during the forecast period of 2024 to 2029.
Browse 495 market data Tables and 50 Figures spread through 456 Pages and in-depth TOC on "Fill Finish Manufacturing Market by Product (Consumables (Pre-fillable Syringes (Plunger Stopper)), Vial (Glass, Plastic), Cartridge), Instruments ((Standalone, Integrated Systems), Automated Machines), End User (CMO, Pharma) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/fill-finish-manufacturing-market-6249609.html
The fill finish manufacturing market is predicted to grow at a CAGR of 8.9% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing applications in biotechnology & pharmaceutical industries and increasing adoption of pre-filled syringes for parenteral dosages. Rising demand for biologics and vaccines is also expected to drive market growth during the forecast period.
Consumables segment had the largest estimated share of the fill finish manufacturing market
Based on product, the fill finish manufacturing market is segmented into Consumables [Vials, {Glass vials, Plastic vials} Pre-fillable syringes (By Material {Glass and Plastic} and By components {Pre-fillable Syringe Systems & Components, Plunger Stoppers}, vial stoppers, cartridges, other consumables {Ampoules, bottles, bags, seals}] and Instruments (Instruments by System Type [Integrated, Standalone] and Instruments by Machine Type [Automated and Semi-automated]. The consumables segment accounted for the largest estimated share of the Fill-finish manufacturing market in 2023. The dominant share of this segment can primarily be attributed to the increased demand for parenteral drug delivery and rising shift towards biologics and biosimilars
Contract Manufacturing Organizations (CMO’s) take away the largest estimated share of end user segment
Based on end users, the fill finish manufacturing market is classified into Contract Manufacturing Organizations (CMO’s), pharmaceutical and biopharmaceutical companies and other end users (Contract Research Organizations [CROs] and academic research institutions). In 2023, the CMO’s segment was predicted to account for the largest share of the global fill finish manufacturing market. The large share of this end user segment is due to the rising trend of outsourcing, cost efficiency offered by CMO’s, and focus on core competencies.
During the forecast period, Europe exhibited lucrative market growth.
Europe accounted for the largest share of 36.3% of the global Fill finish manufacturing market, followed by North America and the Asia Pacific, with shares of 33.2% and 24.9%, respectively. The key factors driving market growth are established pharmaceutical industry, strategic location and infrastructure, and a collaborative ecosystem. The market in the Asia Pacific is expected to witness the highest growth rate of 9.5% during the forecast period, primarily due to the increasing adoption of self-administration and expansion initiatives by key players such as construction of new manufacturing facilities, capacity expansions, and investments in state-of-the-art equipment and technologies.
The global fill finish manufacturing markets comprises of many key market players competing for markets shares like Syntegon Technology GmbH (Germany), I.M.A. S.P.A. (Italy), BD (US), West Pharmaceutical Services, Inc. (US), Gerresheimer AG (Germany), AptarGroup, Inc. (US), Dätwyler Holding Inc. (Belgium), Berry Global, Inc. (US), Stevanato Group S.p.A. (Italy), OPTIMA (Germany), Bausch+Ströbel (Germany), Groninger & Co. Gmbh (Germany), SGD PHARMA (France), SCHOTT (Germany), Nipro Corporation (Japan), Bausch Advanced Technology Group (US) and Maquinaria Industrial Dara, Sl (Spain).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]